Barnes Wealth Management Group’s Gilead Sciences GILD Stock Holding History

Barnes Wealth Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$408K	Sell	3,229 -39	-1%	-$5.14K	0.19%	119
2026 Q1	$455K	Sell	3,268 -199	-6%	-$27.9K	0.23%	102
2025 Q4	$426K	Sell	3,467 -35	-1%	-$4.25K	0.23%	99
2025 Q3	$389K	Buy	3,502 +1	+0%	+$114	0.21%	102
2025 Q2	$388K	Sell	3,501 -97	-3%	-$10.3K	0.23%	97
2025 Q1	$403K	Sell	3,598 -53	-1%	-$5.47K	0.26%	91
2024 Q4	$337K	Buy	+3,651	New	+$329K	0.23%	97

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Barnes Wealth Management Group's GILD Position: Q2 2026 in Review

Barnes Wealth Management Group reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $5.14K and leaving 3,229 shares worth $408K. The position accounts for 0.19% of the portfolio, ranked #119.

Barnes Wealth Management Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $455K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Barnes Wealth Management Group held 3,229 shares of Gilead Sciences worth $408K as of Q2 2026.
Barnes Wealth Management Group sold 39 Gilead Sciences shares in Q2 2026, an estimated $5.14K.
Gilead Sciences made up 0.19% of Barnes Wealth Management Group's portfolio in Q2 2026, its #119 holding.
Barnes Wealth Management Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
Barnes Wealth Management Group's Gilead Sciences position peaked at $455K in Q1 2026.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Barnes Wealth Management Group's 13F filing for Q2 2026, filed 24 Jul 2026.